Csenge Advisory Group’s Abbott ABT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.5M | Buy |
16,485
+1,434
| +10% | +$131K | 0.06% | 241 |
|
|
2026
Q1 | $1.55M | Buy |
15,051
+739
| +5% | +$83.4K | 0.07% | 226 |
|
|
2025
Q4 | $1.79M | Sell |
14,312
-12,522
| -47% | -$1.6M | 0.08% | 197 |
|
|
2025
Q3 | $3.59M | Buy |
26,834
+7,949
| +42% | +$1.04M | 0.17% | 114 |
|
|
2025
Q2 | $2.52M | Sell |
18,885
-422
| -2% | -$55.6K | 0.13% | 130 |
|
|
2025
Q1 | $2.53M | Buy |
19,307
+3,356
| +21% | +$427K | 0.14% | 129 |
|
|
2024
Q4 | $1.8M | Sell |
15,951
-104
| -0.6% | -$12K | 0.1% | 164 |
|
|
2024
Q3 | $1.86M | Sell |
16,055
-483
| -3% | -$53K | 0.1% | 158 |
|
|
2024
Q2 | $1.72M | Sell |
16,538
-2,193
| -12% | -$233K | 0.1% | 156 |
|
|
2024
Q1 | $2.13M | Buy |
18,731
+1,182
| +7% | +$136K | 0.12% | 135 |
|
|
2023
Q4 | $1.93M | Buy |
17,549
+1,918
| +12% | +$192K | 0.12% | 149 |
|
|
2023
Q3 | $1.51M | Sell |
15,631
-1,099
| -7% | -$115K | 0.1% | 164 |
|
|
2023
Q2 | $1.82M | Buy |
16,730
+2,037
| +14% | +$217K | 0.12% | 133 |
|
|
2023
Q1 | $1.49M | Buy |
14,693
+957
| +7% | +$101K | 0.11% | 155 |
|
|
2022
Q4 | $1.51M | Sell |
13,736
-887
| -6% | -$91.8K | 0.12% | 157 |
|
|
2022
Q3 | $1.42M | Buy |
14,623
+430
| +3% | +$45.8K | 0.12% | 161 |
|
|
2022
Q2 | $1.54M | Buy |
14,193
+534
| +4% | +$60.6K | 0.13% | 153 |
|
|
2022
Q1 | $1.62M | Buy |
13,659
+3,561
| +35% | +$441K | 0.13% | 145 |
|
|
2021
Q4 | $1.18M | Sell |
10,098
-2,448
| -20% | -$313K | 0.11% | 167 |
|
|
2021
Q3 | $1.47M | Buy |
12,546
+2,448
| +24% | +$301K | 0.12% | 144 |
|
|
2021
Q2 | $1.18M | Buy |
10,098
+1,073
| +12% | +$125K | 0.11% | 167 |
|
|
2021
Q1 | $1.09M | Sell |
9,025
-357
| -4% | -$42.3K | 0.11% | 145 |
|
|
2020
Q4 | $1.03M | Sell |
9,382
-661
| -7% | -$71.8K | 0.12% | 130 |
|
|
2020
Q3 | $1.07M | Buy |
10,043
+1,073
| +12% | +$109K | 0.15% | 116 |
|
|
2020
Q2 | $820K | Sell |
8,970
-1,224
| -12% | -$111K | 0.12% | 140 |
|
|
2020
Q1 | $804K | Buy |
10,194
+2,945
| +41% | +$246K | 0.21% | 104 |
|
|
2019
Q4 | $630K | Buy |
7,249
+506
| +8% | +$42.4K | 0.16% | 125 |
|
|
2019
Q3 | $564K | Sell |
6,743
-1,713
| -20% | -$146K | 0.15% | 130 |
|
|
2019
Q2 | $711K | Buy |
+8,456
| New | +$666K | 0.24% | 77 |
|
|
2018
Q4 | – | Sell |
-449
| Closed | -$31K | – | 199 |
|
|
2018
Q3 | $31K | Buy |
+449
| New | +$29.5K | 0.01% | 331 |
|
Other funds holding ABT
Csenge Advisory Group's ABT Position: Q2 2026 in Review
Csenge Advisory Group increased its Abbott (ABT) stake by 9.5% in Q2 2026, buying an estimated $131K and bringing the position to 16,485 shares worth $1.5M. The position accounts for 0.06% of the portfolio, ranked #241.
Csenge Advisory Group first reported a position in ABT in Q3 2018 and has held it in 30 quarters since. The position peaked at $3.59M in Q3 2025. 2,972 funds tracked by Wall St. Rank hold ABT as of Q2 2026.
- Csenge Advisory Group held 16,485 shares of Abbott worth $1.5M as of Q2 2026.
- Csenge Advisory Group bought 1,434 Abbott shares in Q2 2026, an estimated $131K.
- Abbott made up 0.06% of Csenge Advisory Group's portfolio in Q2 2026, its #241 holding.
- Csenge Advisory Group first reported a position in Abbott in Q3 2018 and has held it in 30 quarters since.
- Csenge Advisory Group's Abbott position peaked at $3.59M in Q3 2025.
- 2,972 funds tracked by Wall St. Rank held Abbott as of Q2 2026.
Based on Csenge Advisory Group's 13F filing for Q2 2026, filed 10 Aug 2026.